Moors & Cabot, Inc. - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 157 filers reported holding BEAM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.8%.

Quarter-by-quarter ownership
Moors & Cabot, Inc. ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$216,000
-28.0%
3,7700.0%0.01%
-27.8%
Q4 2021$300,000
-6.2%
3,770
+2.7%
0.02%
-10.0%
Q3 2021$320,000
-40.4%
3,670
-12.0%
0.02%
-47.4%
Q2 2021$537,000
+123.8%
4,170
+39.0%
0.04%
+111.1%
Q1 2021$240,000
-2.4%
3,0000.0%0.02%
-14.3%
Q4 2020$246,0003,0000.02%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$304,095,00029.88%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,391$28,881,00022.15%
HSG Holding Ltd 796,089$102,465,0007.14%
DC Investments Management, LLC 21,010$2,704,0006.36%
PATHWAY CAPITAL MANAGEMENT, LP 112,197$14,441,0005.74%
Redmile Group, LLC 2,052,506$264,178,0003.91%
Casdin Capital, LLC 818,820$105,390,0002.68%
Darwin Global Management, Ltd. 126,985$16,344,0002.64%
Evolutionary Tree Capital Management, LLC 44,032$5,667,0002.61%
HHLR ADVISORS, LTD. 1,845,753$237,567,0002.44%
View complete list of BEAM THERAPEUTICS INC shareholders